Specific genetic mutations such as the apolipoprotein L1 (APOL1), non‐muscle myosin heavy chain 9 (MYC) and uromodulin (UMOD) are associated with an increased risk for CKD in the general population.39 The gene discussed is APOL1; the disease is chronic kidney disease.